Treatment of abnormalities of the first metatarsophalangeal...

Details Treatment of abnormalities of the first metatarsophalangeal... Treatment of abnormalities of the first metatarsophalangeal...

A - Human Necessities

61

K

A61K 38/48 (2006.01) A61P 21/00 (2006.01)

Patent

CA 2555939

Disclosed is a use of a neuromuscular toxin in the preparation of a medicament for the treatment of abnormalities of the first metatarsophalangeal joint of the foot of a mammal. Preferred embodiments include use of toxins capable of interfering with the connection between muscle and nerve, e.g. botulinum toxin, in the preparation of medicaments to treat such abnormalities as hallux abductovalgus, hallux varus, hallux limitus, and hallux rigidus.

L'invention concerne l'utilisation d'une toxine neuromusculaire dans la préparation d'un médicament destiné au traitement des anomalies de la première articulation métatarsophalangienne du pied d'un mammifère. Les modes de réalisation de l'invention comprennent des toxines capables d'interférence dans l'interconnexion entre le muscle et le nerf, tel que la toxine botulinique, qui s'utilise dans des préparations pour traiter des anomalies telles que hallux abductovalgus, hallux varus, hallux limitus ou hallux rigidus.

Affiliated with

Also associated with

Rating

Treatment of abnormalities of the first metatarsophalangeal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of abnormalities of the first metatarsophalangeal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of abnormalities of the first metatarsophalangeal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2027333